Cantargia AB (CANTA):企業の財務・戦略的SWOT分析

◆英語タイトル:Cantargia AB (CANTA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH351675FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilizes cell surface receptor as a target to develop a novel antibody based therapy for the treatment of chronic myeloid leukemia and other forms of leukemia. Cantargia provides therapies for the treatment of hematological malignancies that uses the expression of cell surface receptor on hematopoietic stem cells. The company also develops antibody therapeutics to eradicate the leukemia disease causing stem cells. Cantargia is headquartered in Lund, Sweden.

Cantargia AB Key Recent Developments

Mar 19,2021: (R) Cantargia reports positive preclinical safety and efficacy results in the CAN10 project
Feb 17,2021: Invitation to presentation of Cantargia’s Full Year Report for the period January – December 2020 on February 25 at 2.00 p.m. CET
Nov 12,2020: Cantargia publishes interim report for third quarter 2020

This comprehensive SWOT profile of Cantargia AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cantargia AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cantargia AB – Key Information
Cantargia AB – Overview
Cantargia AB – Key Employees
Cantargia AB – Key Employee Biographies
Cantargia AB – Key Operational Heads
Cantargia AB – Major Products and Services
Cantargia AB – History
Cantargia AB – Company Statement
Cantargia AB – Locations And Subsidiaries
Cantargia AB
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cantargia AB – Business Description
Cantargia AB – Corporate Strategy
Cantargia AB – SWOT Analysis
SWOT Analysis – Overview
Cantargia AB – Strengths
Cantargia AB – Weaknesses
Cantargia AB – Opportunities
Cantargia AB – Threats
Cantargia AB – Key Competitors

Section 3 – Company Financial Performance Charts

Cantargia AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cantargia AB, Key Information
Cantargia AB, Key Ratios
Cantargia AB, Share Data
Cantargia AB, Major Products and Services
Cantargia AB, History
Cantargia AB, Key Employees
Cantargia AB, Key Employee Biographies
Cantargia AB, Key Operational Heads
Cantargia AB, Other Locations
Cantargia AB, Subsidiaries
Cantargia AB, Key Competitors
Cantargia AB, SWOT Analysis
Cantargia AB, Ratios based on current share price
Cantargia AB, Annual Ratios
Cantargia AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cantargia AB (CANTA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Malayan Banking Berhad:戦略・SWOT・企業財務分析
    Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務分析
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kyorin Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kyorin Pharmaceutical Co Ltd (Kyorin), a subsidiary of Kyorin Holdings Inc, is a pharmaceutical company that manufactures and markets prescription medicines. The company offers ethical drugs including mucodyne, kipres, desalex, flutiform, pentasa, ketas and uritos. Its ketas product is a pho …
  • Sanderson Farms Inc:戦略・SWOT・企業財務分析
    Sanderson Farms Inc - Strategy, SWOT and Corporate Finance Report Summary Sanderson Farms Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SBS Transit Ltd.:企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Octapharma AG:企業の戦略・SWOT・財務分析
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cellmid Ltd (CDY)-医療機器分野:企業M&A・提携分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd is a developer of therapies and diagnostic tests. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair …
  • Mylan NV (MYL)-医療機器分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務情報
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Advanced Technology Company (ATC):企業の財務・戦略的SWOT分析
    Advanced Technology Company (ATC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Care Hospitals:製薬・医療:M&Aディール及び事業提携情報
    Summary Care Hospitals is a healthcare service provider that offers medical care services. The center operates through its specialty departments such as anesthesiology, clinical psychology, obstetrics and gynecology, dietetics and nutrition, ophthalmology and hematology, emergency and general medici …
  • ConocoPhillips (COP):企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • BioHorizons Inc-医療機器分野:企業M&A・提携分析
    Summary BioHorizons Inc (BioHorizons), a subsidiary of Henry Schein Inc is a medical device company that manufactures and develops dental products. The company’s products include dental implants, short implants, guided surgery kits, and others. It provides overdentures, gum grafting and bone graftin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆